Andrea Rachel LEUBITZ,Naamit SHER,Erez FEIGE,Eyal BREITBART
申请号：
US16505130
公开号：
US20200046852A1
申请日:
2019.07.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention provides methods of inducing or improving responsiveness to a VEGF antagonist to a subject or a subject population comprising administering an adenovirus comprising a nucleic acid construct comprising a F AS-chimera gene operably linked to an endothelial cell-specific promoter and administering the VEGF antagonist.
